Dark

RGC
Regencell Bioscience Holdings Limited
stock NASDAQ

Market Open

May 9, 2025 1:55:02 PM EDT

309.50USD+45.991%(+97.50)95,586

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 9, 2025 9:15:30 AM EDT

233.29USD+10.042%(+21.29)508

After-hours

May 8, 2025 4:34:30 PM EDT

217.30USD+2.976%(+6.28)0

Overview HistoricalExchangesShortsNews

Dec 13, 2021

08:35AM EST Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors Business Wire

Nov 22, 2021

08:25AM EST Regencell Bioscience Holdings Highlights $1M Share Purchase By CEO Benzinga

08:15AM EST Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO Business Wire

08:00AM EST Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index Business Wire

Nov 2, 2021

10:56AM EDT RGC: Traditional Chinese Medicine Approach for treatment of neurodevelopmental conditions Benzinga

Sep 30, 2021

10:26AM EDT Regencell Bioscience Holdings Ltd. (RGC) shares are sliding on Thursday morning trade, in search of new support. The shares have been trending down after reaching a year-to-date high on August 25. There were no corporate announcements on the day to impact stock movement. RTTNews

06:30AM EDT The following are some of the stocks making big moves in Thursday's pre-market trading (as of 6.15 A.M. EDT). RTTNews

Sep 27, 2021

12:34PM EDT EXCLUSIVE: Regencell Bioscience COO, James Chung & Paul Niewiadomski, Director Now Interviewing On Benzinga's Power Hour Show Benzinga

12:34PM EDT EXCLUSIVE: Regencell Bioscience COO, James Chung & Paul Niewiadomski, Director To Appear On Benzinga's Power Hour Show At 12: 30 p.m. EDT Benzinga

Sep 2, 2021

08:14AM EDT Regencell Bioscience-Honor Epic JV To Offer COVID-19 Related Treatments To Patients In ASEAN Countries RTTNews

08:01AM EDT Regencell Bioscience Reports Established Joint Venture To Offer COVID Treatment Benzinga

08:00AM EDT Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment Business Wire

Aug 26, 2021

10:19AM EDT Mid-Morning Market Update: Markets Mixed; Dollar General Profit Beats Views Benzinga

08:09AM EDT The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO Benzinga

Aug 25, 2021

02:34PM EDT Mid-Afternoon Market Update: Dow Rises 100 Points; ScanSource Shares Surge Following Q4 Results Benzinga

02:14PM EDT Mid-Day Market Update: Gold Down 1%; Locust Walk Acquisition Shares Jump Benzinga

02:13PM EDT Mid-Morning Market Update: Markets Edge Higher; Dick's Sporting Goods Beats Q2 Views Benzinga

12:13PM EDT Mid-Day Market Update: Gold Down 1%; Locust Walk Acquisition Shares Jump Benzinga

10:18AM EDT Mid-Morning Market Update: Markets Edge Higher; Dick's Sporting Goods Beats Q2 Views Benzinga

10:04AM EDT Shares of Regencell Bioscience Holdings Limited (RGC) more than doubled on Wednesday morning despite no stock related news to drive the shares. RTTNews

Aug 23, 2021

02:44PM EDT Mid-Afternoon Market Update: Dow Gains 270 Points; Vivos Therapeutics Shares Spike Higher Benzinga

12:14PM EDT Mid-Day Market Update: Crude Oil Surges 5%; Staffing 360 Solutions Shares Plunge Benzinga

10:06AM EDT Mid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Trillium Therapeutics Benzinga

Aug 20, 2021

08:00AM EDT Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter's Over-Allotment Option Business Wire

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 9, 2021

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Aug 5, 2021

08:00AM EDT Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders Business Wire

Jul 22, 2021

11:34AM EDT The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO Benzinga

Jul 21, 2021

07:52AM EDT The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay Benzinga

Jul 20, 2021

04:05PM EDT Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering Business Wire

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 16, 2021

11:10AM EDT Regencell Bioscience Shares Open For Trade At $12; IPO Priced At $9.50/Share Benzinga

09:52AM EDT Regencell Bioscience Shares Will Open For Quote At 11 a.m. EDT, Expected To Open For Trade After 11:10 a.m. EDT; IPO Priced At $9.50/Share Benzinga

Jul 15, 2021

05:59PM EDT Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering Business Wire